BRIEF-Amarin says FDA has not accepted its appeal to review Vascepa on procedural grounds
November 22, 2013 at 06:57 AM EST
Nov 22 (Reuters) - Amarin : * On November 21 received notification from FDA that it has not accepted
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.